Home Cart Sign in  
Chemical Structure| 537705-07-0 Chemical Structure| 537705-07-0

Structure of 537705-07-0

Chemical Structure| 537705-07-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 537705-07-0 ]

CAS No. :537705-07-0
Formula : C6H9NO2
M.W : 127.14
SMILES Code : O=C(NCC#C)COC
MDL No. :MFCD11100899

Safety of [ 537705-07-0 ]

Application In Synthesis of [ 537705-07-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 537705-07-0 ]

[ 537705-07-0 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 537705-05-8 ]
  • [ 537705-07-0 ]
  • [ 383432-38-0 ]
YieldReaction ConditionsOperation in experiment
59% 2-METHYL-2-BUTENE (0.59 ML, 5.60 MMOL, 2.8 EQUIV. ) WAS ADDED OVER 1 HOUR TO A COLD (0-5C) SOLUTION OF BH3*THF COMPLEX (1.0 M SOL, 3.0 ML, 3.0 MMOL, 1.5 EQUIV. ) KEPT UNDER N2. The reaction mixture was stirred at this temperature for 30 minutes followed by the addition of 2-METHOXY-ACETIC ACID PROPARGYLAMIDE (255 MG, 2 MMOL, 1.0 EQUIV. ) DISSOLVED IN DRY THF (1 ML) over 15 minutes. The ice-bath was removed and the reaction mixture was warmed to room temperature over 20 minutes. The reaction mixture was then heated at 35C for 1 hour. K2CO3 (0.55 G, 4 MMOL, 2.0 EQUIV. ) DISSOLVED IN DEGASSED H20 (1.2 ML) WAS ADDED OVER 30 minutes to the reaction mixture. During the addition of the first half gas evolution was observed which seized during further addition. 6-lodo- [3-methyl-4- (6-methyl-pyridine-3-yloxy)- PHENYLAMINO]-QUINAZOLINE (1.41 G, 3 MMOL, 1.5 EQUIV. ) WAS ADDED IN THREE PORTIONS GIVING A yellow suspension. PPH3 (21 mg, 0.08 mmol, 4 mol%) and Pd (OAc) 2 (4.5 mg, 0.02 MMOL, 1 mol%) were added each in one portion and the reaction mixture was heated to reflux (65- 68C). After about 30 minutes a yellow solution was obtained and the reaction was monitored by HPLC assay. After 18 hours the reaction mixture was cooled to room temperature followed by the addition of half-saturated NACI solution (10 ml) and EtOAc (10 ML). The organic phase was separated, washed with H2O (5 ML) and concentrated at 50C and a pressure of less than 200 mbar. Purification by plug filtration, Si02, EtOAc/MeOH = 9/1. The title compound was obtained as light yellow crystals (0.55 g, 59 %). Rf = 0.16 (EtOAc/MeOH = 9/1). H-NMR (CDCI3, 250 MHz): 8 =8.71 (s, 1 H, H-2), 8.25 (d, J=1.7 Hz, 1 H, H-8), 7.90 (s, 1 H, H-7), 7.82 (s, 1H, NH), 7.79 (s, 1H, H-5), 7.66 (d, J=2.5Hz, 1H, H-4"), 7.54 (dd, JE=8. 7Hz, J2=2. 6Hz, 1H, H- 5"), 7.15-7. 07 (m, 2H, H-5', H-6'), 6.91 (d, J=8.7Hz, 1 H, H-2'), 6.83 (bt, 1H, NH), 6.65 (d, J=15.9Hz, 1H, H-9), 6.34 and 6.29 (dt, JE=15. 9Hz, J2=6. 1HZ, 1H, H-10), 4.14 (dt, J=6. 1Hz, 2H, CHzOMe), 3.97 (s, 2H, CH2NH), 3.45 (s, 3H, OCH3), 2.53 (s, 3H, CH3), 2.29 (s, 3H, CH3). '3C-NMR (CDCI3, 75 MHz): 8= 169.76 (C=O), 157.90, 154.93, 152.367, 152.23, 150.90, 149.74, 139.34, 134.73, 134.63, 131.16, 130.77, 130.36, 128.85, 129.98, 125.47, 124.66, 123.65, 121.32, 119.51, 119.13, 115.39, 71.96, 59.26, 40.84, 23.57, 16.41. Using reverse phase high performance liquid chromatography tR (min) was found to be 6.02 for the title compound under the conditions shown in the following table. Symmetry Shield 75 x 4.6 mm RP18 Flow 1. 0 mL/min Wavelength 205/210/220/245 nm Temp. 25C Injection Volume 10 LL of a ca. 0.5% solution in ACN/H20 9/1 Eluent B ACN Eluent C 0.01 mmol NH40Ac in H2O pH = 6.0 Gradient 0 min B = 30%, C = 70 % Gradient 20 min B = 85%, C = 15 %
59% Preparation of 2-methyl-2-butene (0.59 ml, 5.60 mmol, 2.8 equiv.) was added over 1 hour to a cold (0-5 C.) solution of BH3*THF complex (1.0 M sol, 3.0 ml, 3.0 mmol, 1.5 equiv.) kept under N2. The reaction mixture was stirred at this temperature for 30 minutes followed by the addition of 2-Methoxy-acetic acid propargylamide (255 mg, 2 mmol, 1.0 equiv.) dissolved in dry THF (1 ml) over 15 minutes. The ice-bath was removed and the reaction mixture was warmed to room temperature over 20 minutes. The reaction mixture was then heated at 35 C. for 1 hour. K2CO3 (0.55 g, 4 mmol, 2.0 equiv.) dissolved in degassed H2O (1.2 ml) was added over 30 minutes to the reaction mixture. During the addition of the first half gas evolution was observed which seized during further addition. 6-Iodo-[3-methyl-4-(6-methyl-pyridine-3-yloxy)-phenylamino]-quinazoline (1.41 g, 3 mmol, 1.5 equiv.) was added in three portions giving a yellow suspension. PPh3 (21 mg, 0.08 mmol, 4 mol %) and Pd(OAc)2 (4.5 mg, 0.02 mmol, 1 mol %) were added each in one portion and the reaction mixture was heated to reflux (65-68 C.). After about 30 minutes a yellow solution was obtained and the reaction was monitored by HPLC assay. After 18 hours the reaction mixture was cooled to room temperature followed by the addition of half-saturated NaCl solution (10 ml) and EtOAc (10 ml). The organic phase was separated, washed with H2O (5 ml) and concentrated at 50 C. and a pressure of less than 200 mbar. Purification by plug filtration, SiO2, EtOAc/MeOH=9/1. The title compound was obtained as light yellow crystals (0.55 g, 59%). Rf=0.16 (EtOAc/MeOH=9/1). 1H-NMR (CDCl3, 250 MHz): delta=8.71 (s, 1H, H-2), 8.25 (d, J=1.7 Hz, 1H, H-8), 7.90(s, 1H, H-7), 7.82 (s, 1H, NH), 7.79 (s, 1H, H-5), 7.66 (d, J=2.5 Hz, 1H, H-4), 7.54 (dd, J1=8.7 Hz, J2=2.6 Hz, 1H, H-5), 7.15-7.07 (m, 2H, H-5', H-6'), 6.91 (d, J=8.7 Hz, 1H, H-2'), 6.83 (bt, 1H, NH), 6.65 (d, J=15.9 Hz, 1H, H-9), 6.34 and 6.29 (dt, J1=15.9 Hz, J2=6.1 Hz, 1H, H-10), 4.14 (dt, J=6.1 Hz, 2H, CH2OMe), 3.97 (s, 2H, CH2NH), 3.45 (s, 3H, OCH3), 2.53 (s, 3H, CH3), 2.29 (s, 3H, CH3). 13C-NMR (CDCl3, 75 MHz): delta=169.76 (CO), 157.90, 154.93, 152.367, 152.23, 150.90, 149.74, 139.34, 134.73, 134.63, 131.16, 130.77, 130.36, 128.85, 129.98, 125.47, 124.66, 123.65, 121.32, 119.51, 119.13, 115.39, 71.96, 59.26, 40.84, 23.57, 16.41.
  • 2
  • [ 537705-07-0 ]
  • [ 383432-38-0 ]
 

Historical Records

Technical Information

Categories